NSE close · Mon, 28 SeptNifty 5022,780.25▼ 1.56%Nifty Bank54,471.65▼ 1.99%Midcap 10059,914.20▼ 1.63%Smallcap 25017,863.20▼ 1.63%India VIX13.64▲ 12.17%IT28,086.50▼ 0.26%Auto26,525.05▼ 1.64%Pharma26,761.65▼ 0.89%FMCG45,264.35▼ 1.47%Metal12,854.40▼ 1.78%Realty850.90▼ 2.12%Energy36,693.20▼ 2.00%PSU Bank8,026.10▼ 3.24%Financials24,671.65▼ 1.69%Media1,539.25▼ 0.74%Defence9,231.20▼ 1.81%Durables38,162.90▼ 0.30%Biggest movesRSYSTEMS▲ 16.8%REPRO▲ 15.8%DAMCAPITAL▲ 14.8%SMCGLOBAL▲ 13.6%BPLPHARMA▲ 13.3%PRIMO▲ 11.3%SSDL▲ 11.2%SYNCOMF▲ 10.7%

Top stories

Bliss GVS Pharma · 2 storiesClear filters

Developing 163 Picking up 16 Price moves 7 Following

Busiest tags today

AI142 Global markets126 Crude oil122 Market valuations119 Nifty and Sensex112 Bond yields95 Geopolitics82 Iran60 Banks59 US Treasuries57 Gold50 Trade and tariffs49 Wall Street48 Inflation41 Every tag in Market pulse →

Company · BLISSGVS

Bliss GVS Pharma● ±0% net tone today

2 stories today · 2 since 29 Sept₹737.65 · +4.68% on Mon, 28 Sept · +11.5% in 5 days

Often with, this weekAnupam Rasayan India2 Pharma and healthcare1

Open tag page →Clear ×

Deal●

Anupam Rasayan completes purchase of 48.2% stake in Bliss GVS Pharma for ₹1,750 cr

Anupam Rasayan acquired a 48.2% stake in Bliss GVS Pharma for ₹1,750 cr
The deal was priced at ₹299 per share, with an open offer and on-market top-up
The acquisition affects Anupam Rasayan and Bliss GVS Pharma shareholders

Anupam Rasayan India Bliss GVS Pharma Pharma and healthcare1 source · 3h

Expansion●

Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platform

Anupam Rasayan India Bliss GVS Pharma1 source · 3h

That’s everything for today